Optomed Oyj

Optomed Plc is a Finnish medical technology company specializing in handheld fundus cameras and AI-powered eye-screening solutions. Founded in 2004 and based in Oulu, Optomed develops portable retinal imaging technology for early detection of eye diseases, particularly diabetic retinopathy and related conditions. The company manufactures non-mydriatic fundus cameras including the Smartscope Pro and FDA-cleared Aurora AEYE, integrated with artificial intelligence for enhanced diagnostic accuracy. Optomed's software portfolio—Avenue AI, Avenue Eye Screen, Avenue Flow, and Avenue Telemedicine—enables ophthalmologists, primary care physicians, and pediatricians to manage workflows and conduct remote eye screenings efficiently. The platform supports telemedicine consultations and oculomics analysis for disease monitoring. Optomed serves clinical settings globally through subsidiaries in China and the United States, positioning handheld retinal imaging as accessible screening for diverse patient populations in both primary and specialist care environments.